EP3828173
SETIN PÝRASÓLSAMBÖND SEM PLASMA KALLIKREIN-HEMLAR Í MÖNNUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.3.2015EP published:
31.8.2022EP application number:
20191747.3
EP translation filed:
1.11.2022Grant published:
15.12.2022EPO information:
European Patent Register
Max expiry date:
8.3.2035Expiry date:
8.3.2027Next due date:
31.3.2027
Title in English:
SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORSLanguage of the patent:
English
Timeline
Today
9.3.2015EP application
31.8.2022EP Publication
1.11.2022Translation submitted
15.12.2022Registration published
8.3.2027Expires
Owner
Name:
BioCryst Pharmaceuticals, Inc.Address:
4505 Emperor Blvd., Durham, NC 27703, US
Inventor
Name:
KOTIAN, Pravin L.Address:
Hoover, Alabama 35226, US
Name:
BABU, Yarlagadda S.Address:
Birmingham, Alabama 35244, US
Name:
WU, MinwanAddress:
Vestavia Hills, Alabama 35226, US
Name:
CHINTAREDDY, Venkat RAddress:
Vestavia Hills, Alabama 35216, US
Name:
KUMAR, Satish VAddress:
Birmingham, Alabama 35244, US
Name:
ZHANG, WeiheAddress:
Vestavia, Alabama 35226, US
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
201461949808 PDate:
7.3.2014Country:
US
Number:
201461981515 PDate:
18.4.2014Country:
US
Supplementary protection
SPC number:
SPC410
Classification
Categories:
C07D 231/14, A61K 31/415
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 8.2.2023
Expires: 8.3.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 22.1.2024
Expires: 8.3.2025
Payer: Pintz & Partners LLC
Number: 11
Paid: 20.1.2025
Expires: 8.3.2026
Payer: UAB METIDA
Number: 12
Paid: 20.1.2026
Expires: 8.3.2027
Payer: UAB METIDA